The Sigma Healthcare Ltd (ASX: SIG) share price is in focus today after revealing Chemist Warehouse branded stores have grown Australian sales by 12.1% and international sales by 30.2% since July.
What did Sigma Healthcare report?
- Australian Chemist Warehouse branded store sales up 12.1% (1 July – 16 October 2026)
- Australian like-for-like sales increased 9.8%
- International Chemist Warehouse sales rose 30.2% (constant currency, 1 July – 30 September 2026)
- International like-for-like sales up 15.8%
- On track to open 14 Chemist Warehouse stores and 42 Amcal and Discount Drug Stores in Australia first half FY27
- Global pharmacy network approaching 1,000 stores
What else do investors need to know?
Chemist Warehouse stores continue to show solid momentum, despite some softness in discretionary categories like ladies’ fragrances and supplements as shoppers respond to cost-of-living pressures. Less discretionary categories—including healthcare, beauty, and GLP-1 supporting products—performed strongly.
Sigma is making steady progress on expanding its global footprint. In addition to the planned store openings in Australia, another 19 international stores are scheduled to be onboarded in the first half of FY27. The group continues to focus on operational efficiencies, while revitalising the Amcal and Discount Drug Stores banners to support domestic growth.
What did Sigma Healthcare management say?
Our business model is very defensive and resilient. Chemist Warehouse, with the breadth and depth of its discount offer, provides increased opportunities through the cycle. We have a clear plan, strong momentum and significant opportunities still ahead. Our job is to keep executing on our strategy, and to turn that execution into sustainable value for shareholders.
What’s next for Sigma Healthcare?
Managing Director and CEO Vikesh Ramsunder said:
Sigma expects Chemist Warehouse branded stores to continue posting double-digit sales growth over the remainder of the half, helped by the upcoming Christmas trading period. The company also anticipates the introduction of oral GLP-1 products in the second half of FY27, aiming to further drive patient access and store sales.
With just under 10% market share of Australia’s pharmacy licences, Sigma sees substantial room to grow its network of Chemist Warehouse branded stores, alongside the ongoing revitalisation of Amcal and Discount Drug Stores. The company’s disciplined growth agenda and strong current momentum signal continued focus on sustainable shareholder value.
Sigma Healthcare share price snapshot
Over the past 12 months, Sigma shares have declined 10%, trailing the S&P/ASX 200 Index (ASX: XJO), which has fallen 3% over the same period.
The post Sigma Healthcare provides Chemist Warehouse sales update appeared first on The Motley Fool Australia.
Wondering where to invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…
* Returns as of 6 March 2025
More reading
- 5 things to watch on the ASX 200 on Wednesday
- Which ASX retailer is a better buy, Coles or Woolworths?
- Buy, hold, sell: Sigma Healthcare, Collins Foods, IKO ETF shares
- Guess which ASX 200 share was just hit with a broker downgrade
- 5 things to watch on the ASX 200 on Tuesday
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.